Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells

[1]  M. King,et al.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.

[2]  J. Mazat,et al.  The role of adenine nucleotide translocation in the energization of the inner membrane of mitochondria isolated from ϱ+ and ϱo strains of saccharomyces cerevisiae , 1985 .

[3]  M. Murphy,et al.  Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA. , 1999, European journal of biochemistry.

[4]  C. Warren Olanow,et al.  Tolcapone and Hepatotoxic Effects , 2000 .

[5]  P. Bernardi,et al.  Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. , 1993, The Journal of biological chemistry.

[6]  S. Gasser,et al.  Import of proteins into mitochondria. Energy-dependent uptake of precursors by isolated mitochondria. , 1982, The Journal of biological chemistry.

[7]  Dean P. Jones,et al.  Cytochrome c-mediated Apoptosis in Cells Lacking Mitochondrial DNA , 1999, The Journal of Biological Chemistry.

[8]  J. Nutt,et al.  Effect of peripheral catechol‐O‐methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients , 1994, Neurology.

[9]  S. Kaakkola,et al.  Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. , 1992, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[10]  P. Watkins,et al.  COMT inhibitors and liver toxicity. , 2000, Neurology.

[11]  G. Sedek,et al.  Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa. , 1995, British journal of clinical pharmacology.

[12]  J. Šubík,et al.  Genetic determination of the mitochondrial adenine nucleotide translocation system and ITS role in the eukaryotic cell , 1977, Molecular and Cellular Biochemistry.

[13]  C. Adler,et al.  Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations , 1997, Neurology.

[14]  P. Kaheinen,et al.  Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production. , 1997, European journal of pharmacology.

[15]  F. Assal,et al.  Tolcapone and fulminant hepatitis , 1998, The Lancet.

[16]  E. Nissinen,et al.  Different toxicological profile of two COMT inhibitors in vivo: the role of uncoupling effects , 2002, Journal of Neural Transmission.

[17]  G. Kroemer,et al.  Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. , 1996, Cancer research.

[18]  I. Lindén,et al.  Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat , 2001, Journal of Neural Transmission.

[19]  K. Penttilä,et al.  Effects of entacapone and tolcapone on mitochondrial membrane potential. , 2002, European journal of pharmacology.

[20]  M. King,et al.  Isolation of human cell lines lacking mitochondrial DNA. , 1996, Methods in enzymology.

[21]  Sarah J. Tabrizi,et al.  Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity , 2000 .

[22]  G. Rödel,et al.  A fluorescence-microscopic and flow-cytometric study of HeLa cells with an experimentally induced respiratory deficiency. , 1992, Biochemical and biophysical research communications.

[23]  P. Bernardi,et al.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. II. The minimal requirements for pore induction underscore a key role for transmembrane electrical potential, matrix pH, and matrix Ca2+. , 1993, The Journal of biological chemistry.

[24]  M. Crompton,et al.  The mitochondrial permeability transition pore. , 1999, Biochemical Society symposium.

[25]  P. Reynier,et al.  Oxygen consumption and expression of the adenine nucleotide translocator in cells lacking mitochondrial DNA. , 2002, Experimental cell research.